Join the Ketamine group to help and get support from people like you.
Ketamine News
Extended-Release Oral Ketamine Effective for Treatment-Resistant Depression
WEDNESDAY, July 17, 2024 – For patients with treatment-resistant depression, racemic ketamine, given as an extended-release tablet (R-107), administered orally, is effective, safe, and well...
Slow-Release Ketamine Pill Eases Depression: Study
TUESDAY, June 25, 2024 – A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research...
IV Ketamine Not a 'Silver Bullet' for Depression, but Does Help Some
FRIDAY, Feb. 9, 2024 – Nearly half of Veterans Health Administration (VA) patients with treatment-resistant depression who received intravenous (IV) ketamine saw a meaningful drop in depression...
Veterans' Study Shows Effectiveness of Ketamine Against Depression
TUESDAY, Feb 6, 2024 – The former 'party drug' ketamine has gotten some good press recently, with clinical trials suggesting it might be a powerful and fast-acting antidepressant. Now, one of the...
Many Clinics Are Selling Ketamine as Bogus 'Cure' for Illnesses
TUESDAY, Nov. 14, 2023 – The party drug and anesthetic ketamine is starting to show promise in trials as a treatment for depression. But new research also suggests that hundreds of U.S. clinics may...
Ketamine No Better Than Placebo for Depression
WEDNESDAY, Oct. 25, 2023 – For patients with major depressive disorder, a single dose of intravenous ketamine delivered during surgical anesthesia has no greater effect than placebo, according to a...
Ketamine's Antidepressant Benefit: Is It All in Your Head?
TUESDAY, Oct. 24, 2023 – The party drug ketamine has gotten a lot of notice for its potential to help people with severe and persistent depression who haven't responded to other treatments. But a...
FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
WEDNESDAY, Oct. 11, 2023 – The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders. Compounded...
FDA Medwatch Alert: FDA Warns Patients and Health Care Providers About Potential Risks Associated With Compounded Ketamine Products
October 10, 2023 – There is increased interest in compounded ketamine products (including oral formulations) for the treatment of psychiatric disorders. When considering use of compounded ketamine...
MDMA/Ecstasy Shows Even More Promise in Easing PTSD
THURSDAY, Sept. 14, 2023 – A new study is adding to evidence that the party drug "ecstasy" can boost the benefits of talk therapy for people suffering from post-traumatic stress disorder (PTSD). In...
FDA Medwatch Alert: General Anesthetic and Sedation Drugs: Drug Safety Communication - FDA Approves Label Changes for Use in Young Children
ISSUE: FDA has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning...
FDA Medwatch Alert: General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women
ISSUE: FDA is warning that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third...
FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
[Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...
Ask a question
To post your own question to this support group, sign in or create an account.